Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Validation of a novel multi-luminance shape discrimination test for assessment of functional vision.
Validation of a novel multi-luminance shape discrimination test for assessment of functional vision.
Journal: Documenta ophthalmologica. Advances in ophthalmology
Published: July 15, 2025
Safety and efficacy of MCO-010 optogenetic therapy in patients with Stargardt disease in USA (STARLIGHT): an open-label multi-center Ph2 trial.
Journal: EClinicalMedicine
Published: June 25, 2025
Response: Promise and open questions of optogenetic vision restoration by MCO.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: April 10, 2025
A synthetic opsin restores vision in patients with severe retinal degeneration.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: February 18, 2025
A Phase I, Single Ascending Dose Study of GEM103 (Recombinant Human Complement Factor H) in Patients with Geographic Atrophy.
Journal: Ophthalmology science
Published: February 15, 2022
A randomized phase 2 trial of the efficacy and safety of a novel topical povidone-iodine formulation for Cancer therapy-associated Paronychia.
Journal: Investigational new drugs
Published: May 16, 2019
Topical application of povidone-iodine/dimethylsulfoxide ophthalmic gel preparation in Dutch-Belted rabbits.
Journal: Cutaneous and ocular toxicology
Published: February 12, 2019
Keratoprosthesis prophylaxis: is it time for a paradigm shift?
Journal: Clinical ophthalmology (Auckland, N.Z.)
Published: September 27, 2018
Evaluation of optic neuritis following human papillomavirus vaccination.
Journal: Human vaccines & immunotherapeutics
Published: May 03, 2017
Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial.
Journal: American journal of ophthalmology
Published: November 16, 2016
Phase 2a Randomized Clinical Trial: Safety and Post Hoc Analysis of Subretinal rAAV.sFLT-1 for Wet Age-related Macular Degeneration.
Journal: EBioMedicine
Published: November 08, 2016
Showing 1-12 of 12
Last Updated: 09/26/2026